Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00644774 · ClinicalTrials.gov registry record · Phase 4

A Pediatric Taste Test Study of Omnicef Versus Zithromax Antibiotic Suspension Medications

A Phase 4 study of Healthy, sponsored by Abbott.

Completed
Registry status
Phase 4
Development phase
157
Enrollment target
3
Study locations

NCT00644774 is a Phase 4 study of Healthy that has completed, run by Abbott. The registered enrollment target is 157 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (76% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00644774, a Phase 4 study of Healthy, has completed, sponsored by Abbott.

COMPLETED
Registry status
Phase 4
Development phase
157 participants
Enrollment target
3
Study locations

Study Summary

To compare the taste and smell acceptability of cefdinir (Omnicef) antibiotic suspension and azithromycin (Zithromax) antibiotic suspension following a single dose of each medication.

Conditions Studied

Healthy

Interventions

  • DRUG azithromycin
  • DRUG cefdinir (Omnicef)

Study Locations (3)

Arizona

  • - Scottsdale

Florida

  • - St. Petersburg

Ohio

  • - Miamiville

Trial Details

FieldValue
Enrollment Target 157 participants
Start Date 2003-01
Phase Phase 4

Sponsor

Abbott

181 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00644774

The ClinicalTrials.gov registry entry for NCT00644774 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 157 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (76% lower). The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which azithromycin is the first listed.

NCT00644774 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Arizona, Florida, Ohio.

Frequently Asked Questions

What is clinical trial NCT00644774 about?

NCT00644774 is a clinical study titled "A Pediatric Taste Test Study of Omnicef Versus Zithromax Antibiotic Suspension Medications". To compare the taste and smell acceptability of cefdinir (Omnicef) antibiotic suspension and azithromycin (Zithromax) antibiotic suspension following a single dose of each medication.

What is the current status of trial NCT00644774?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 157 participants. The study started on 2003-01.

What conditions does trial NCT00644774 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT00644774?

The interventions under investigation include: azithromycin (DRUG), cefdinir (Omnicef) (DRUG).

Who is sponsoring clinical trial NCT00644774?

This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00644774 being conducted?

This trial has 3 study locations across Arizona, Florida, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.